Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD.

× No keyword cloud information.

19 in total

Review 1. Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder.

Authors: Alexander Neumeister; Jordan Seidel; Benjamin J Ragen; Robert H Pietrzak
Journal: Psychoneuroendocrinology Date: 2014-10-22 Impact factor: 4.905

Review 2. Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned?

Authors: Nancy C Bernardy; Matthew J Friedman
Journal: Curr Psychiatry Rep Date: 2015-04 Impact factor: 5.285

Review 3. Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research.

Authors: Santiago Papini; Gregory M Sullivan; Denise A Hien; Erel Shvil; Yuval Neria
Journal: Biol Psychol Date: 2014-11-04 Impact factor: 3.251

4. Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity.

Authors: Amir Segev; Nachshon Korem; Tomer Mizrachi Zer-Aviv; Hila Abush; Rachel Lange; Garrett Sauber; Cecilia J Hillard; Irit Akirav
Journal: Neuropsychopharmacology Date: 2018-06-27 Impact factor: 7.853

5. PTSD Symptom Clusters and Craving Differs by Primary Drug of Choice.

Authors: Vanessa C Somohano; Kristoffer L Rehder; Tyree Dingle; Taylor Shank; Sarah Bowen
Journal: J Dual Diagn Date: 2019-07-14

6. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.

Authors: Matthew N Hill; Linda M Bierer; Iouri Makotkine; Julia A Golier; Sandro Galea; Bruce S McEwen; Cecilia J Hillard; Rachel Yehuda
Journal: Psychoneuroendocrinology Date: 2013-09-10 Impact factor: 4.905

Review 7. Cannabidiol as a Potential Treatment for Anxiety Disorders.

Authors: Esther M Blessing; Maria M Steenkamp; Jorge Manzanares; Charles R Marmar
Journal: Neurotherapeutics Date: 2015-10 Impact factor: 7.620

8. The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD).

Authors: Viviana Trezza; Patrizia Campolongo
Journal: Front Behav Neurosci Date: 2013-08-09 Impact factor: 3.558

9. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study.

Authors: A Neumeister; M D Normandin; R H Pietrzak; D Piomelli; M Q Zheng; A Gujarro-Anton; M N Potenza; C R Bailey; S F Lin; S Najafzadeh; J Ropchan; S Henry; S Corsi-Travali; R E Carson; Y Huang
Journal: Mol Psychiatry Date: 2013-05-14 Impact factor: 15.992

Review 10. Treatment-refractory anxiety; definition, risk factors, and treatment challenges.

Authors: Peter Roy-Byrne
Journal: Dialogues Clin Neurosci Date: 2015-06 Impact factor: 5.986